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Increased Lipid Peroxidation and Decreased Antioxidant
Response in Serum and Cerebrospinal Fluid in Acute
Ischemic Stroke
Background and Aim: The pathogenesis of brain damage in ischemic stroke is highly complex. The aim of
the present study was to investigate the presence of oxidative stress in ischemic stroke and to determine
whether the measured oxidative stress markers in serum and cerebrospinal fluid (CSF) were associated with
infarction volume, and the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS).
Materials and Methods: The study included 32 patients with acute ischemic stroke within 48 h of onset and
18 suitable controls. Superoxide dismutase (SOD) and glutathione peroxidase (GPX) activity, glutathione (GSH)
and malondialdehyde (MDA) level, and total antioxidant capacity (TAC) were measured in both serum and CSF
samples of the participants.

1

Department of Biochemistry,
Faculty of Medicine,
Atatürk University,
25240 Erzurum - TURKEY

2

Department of Neurology,
Faculty of Medicine
Atatürk University,
25240 Erzurum - TURKEY

3

Department of Physiology,
Faculty of Medicine,
Atatürk University,
25240 Erzurum - TURKEY

Results: GPX activity, GSH level, and TAC in the serum and CSF samples of stroke patients were significantly
lower than those in the controls. In the patient group, SOD activity in serum was lower and SOD activity in
CSF was higher compared to the control group. Both serum and CSF MDA concentrations were significantly
higher among stroke patients as compared to the controls.
Conclusions: The lower activity levels of antioxidant molecules measured in this study could have resulted
from increased free radical generation, which may confirm the presence of oxidative stress in acute ischemic
stroke; however, the levels of oxidative stress markers in serum and CSF may not always be indicative of
neurological deficit.
Key Words: Ischemic stroke, oxidative stress, cerebrospinal fluid, malondialdehyde, total antioxidant capacity

Akut ‹skemik Strokta Serum ve Beyin Omurilik S›v›s›nda Artm›ﬂ Lipid
Peroksidasyonu, Azalm›ﬂ Antioksidan Aktivite
Giriﬂ ve Amaç: ‹skemik strokta beyin hasar›n›n patogenezi oldukça karmaﬂ›kt›r. Bu çal›ﬂman›n amac› iskemik
strokta oksidatif stres varl›¤›n› araﬂt›rmak ve beyin omurilik s›v›s› (CSF) ve serumda ölçülen oksidatif stres
belirteçleriyle infarkt volumu, Glasgow Koma Skalas› ve Glasgow Sonuç Skalas› ile iliﬂkisinin olup olmad›¤›n›
araﬂt›rmakt›.
Yöntem ve Gereç: Bu çal›ﬂma strok baﬂlang›c›ndan 48 saat içinde hastanemize baﬂvuran 32 akut iskemik
stroklu hasta ve uygun kontrol grubu (n = 18) üzerinde yürütüldü. Serum ve CSF örneklerinde superoksit
dismutaz (SOD) ve glutatyon peroksidaz (GPX) aktiviteleri ve total antioksidan kapasite (TAC), glutatyon (GSH)
ve malondialdehit (MDA) düzeyleri ölçüldü.
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Bulgular: Hastalar›n serum ve CSF örneklerinde, GPX aktiviteleri ve GSH düzeyleri ve TAC kontrol grubuna
göre anlaml› ﬂekilde daha düﬂüktü. Kontrol grubu ile karﬂ›laﬂt›r›ld›¤›nda hasta grubu serum örneklerinde
azalm›ﬂ SOD aktivitesi ve CSF örneklerinde ise artm›ﬂ SOD aktivitesi bulundu. Kontrol grubu ile
karﬂ›laﬂt›r›ld›¤›nda stroklu hastalarda hem serum hem de CSF MDA konsantrasyonu daha yüksekti.
Sonuç: Bu çal›ﬂmada ölçülen antioksidan moleküllerin azalm›ﬂ konsantrasyonlar› veya aktiviteleri artm›ﬂ
serbest radikal oluﬂumundan kaynaklanm›ﬂ olabilir, ki bu durum da akut iskemik strokta oksidatif stresin
varl›¤›n› do¤rulayabilir. Bununla birlikte, serum ve CSF’de ölçülen oksidatif stres belirteçlerinin düzeyleri her
zaman nörolojik hasar›n bir göstergesi olmayabilir.
Anahtar Sözcükler: ‹skemik strok, oksidatif stres, beyin omurilik s›v›s›, malondialdehit, total antioksidan
kapasite
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Introduction
Stroke is the third most common cause of death in
industrialized countries, following coronary heart disease
and cancer (1). Ischemic stroke accounts for about 75%
of all strokes. Cerebral infarction in ischemic strokes may
be due to vessel occlusion by an embolus or to primary
thrombosis in an artery (2). The pathogenesis of brain
damage in ischemic stroke is highly complex, and involves
impaired blood-brain barrier permeability, energy failure,
loss of cell ion homeostasis, acidosis, increased
intracellular calcium, excitotoxicity, and free radicalmediated toxicity. Ischemia rapidly causes a cascade of
events that eventually lead to neuronal damage and death
(3,4).
Oxidative stress states occur when cellular antioxidant
defenses are insufficient to keep the levels of reactive
oxygen species (ROS) below a toxic threshold. This may
be due to excessive production of ROS or the failure of
antioxidant defenses, or both (5). Oxidative stress in
cerebral ischemia/reperfusion is a subject of intensive
investigation and is considered to be one of the
mechanisms involved in neuronal damage due to
ischemia/reperfusion in stroke patients (6). Yet, the
mechanisms that participate in the development of
oxidative stress in ischemic stroke are not completely
known. In other words, it is not fully evident if oxidative
stress contributes to the pathogenesis of stroke or if it is
a consequence of pathophysiological processes following
ischemic stroke. Controversial results, which will be
further discussed, are even found in the literature
concerning antioxidant status and lipid peroxidation in
stroke patients (7-10).
Cerebrospinal fluid (CSF) contains both powerful
enzymatic and non-enzymatic antioxidants, and CSF
analysis provides some important clues about the
physiological or pathological changes in the central
nervous system (11). The assessment of lipid
peroxidation products and antioxidant status in CSF may
be important in predicting free radical-induced cerebral
injury in stroke patients. To the best of our knowledge,
there is little information in the literature on the
simultaneous evaluation of oxidative stress markers in
serum and CSF. Therefore, we measured superoxide
dismutase (SOD) and glutathione peroxidase (GPX)
activities, glutathione (GSH) and malondialdehyde (MDA)
levels, and total antioxidant capacity (TAC) in both serum
and CSF samples in patients with acute ischemic stroke
76
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within 48 h of onset, and compared them to a suitable
control group. This study was performed with 2 aims: [1]
to investigate the presence of oxidative stress in ischemic
stroke by measuring the level and activity of several
antioxidants, and MDA concentrations in serum and CSF
samples, and [2] to determine whether the measured
oxidative stress markers in serum and CSF were
associated with infarction volume, and the Glasgow Coma
Scale (GCS) and Glasgow Outcome Scale (GOS).

Materials and Methods
The study included 32 patients (17 male, 15 female)
with acute ischemic stroke, who were admitted to the
Department of Neurology at Atatürk University Hospital
within 48 h of the onset of symptoms. Control subjects
were 18 age- and sex-matched volunteers without
organic disorders of the nervous system, who underwent
lumbar punctures for intrathecal anesthetic drug
administration during orthopedic surgery. The study
protocol was approved by the local ethics committee, and
written informed consent was obtained from each
participant or their relatives before inclusion in the study.
On admission, all strokes were initially diagnosed on
the basis of full physical and neurological examinations.
The diagnoses were then confirmed by an MRI or CT scan
of the brain. Vascular risk factors, including hypertension,
diabetes mellitus, and smoking and alcohol habits, were
recorded. Patients with hemorrhagic stroke, other
neurological diseases, liver disease, renal failure, or
severe medical disease were excluded.
Patients were clinically evaluated using the GCS, and
functional outcome at discharge was assessed using the
GOS. The GOS evaluates clinical outcome with a functional
status scale comprised of 5 items; one point represents
the best score (recovery), whereas 5 points constitutes
the worst result (death). On the basis of clinical and
neuroradiological criteria, it was possible to distinguish
patients with lacunar or non-lacunar syndromes,
including total anterior, partial anterior, and posterior
syndromes.
Blood samples were collected in vacutainer tubes
without any additive on the second day following stroke
onset and also from the control subjects. We collected 4
ml of CSF from the patients and controls in a clean tube
for biochemical analyses. All blood samples were
centrifuged at 3500 x g for 5 min at 4 °C. We mixed 500
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µl of serum with an equal volume of 10%
metaphosphoric acid for measurement of GSH before
freezing at –80 °C. For the other biochemical
measurements, serum aliquots were stored at –80 °C
until analysis. CSF samples were immediately stored at
–80 °C until the biochemical analyses were performed.
MDA level in CSF and serum was used as the indicator
of lipid peroxidation, and were determined by the
thiobarbituric acid (TBA) method, as previously described
(12). Briefly, 0.2 ml of sample was combined with 0.2 ml
of 8.1% SDS, 1.5 ml of 20% acetic acid, 1.5 ml of 0.8%
TBA solution, and 0.6 ml of distilled water, and incubated
at 95 °C for 1 h. After n-butanol/pyridine (15:1, v/v)
extraction, absorbance of the pink chromophore was read
at 532 nm. Tetramethoxypropane (5 nM) was used as the
standard solution, and MDA levels were expressed as
µmol/l.
SOD activity was measured in serum and CSF using
the SOD Assay Kit (Cayman Chemical, Ann Arbor, MI,
USA), according to the manufacturer’s instructions. The
assay uses a tetrazolium salt for detection of superoxide
radicals generated by xanthine oxidase and hypoxanthine,
which yields a chromophore with a maximal absorbance
at 525 nm. One unit of SOD is defined as the amount of
enzyme needed to exhibit 50% dismutation of the
superoxide radical. SOD activity was expressed as U/ml.
GPX activity was quantified in serum and CSF samples
using a kinetic colorimetric assay from Cayman Chemical.
The assay kit measures GPX activity indirectly by a
coupled reaction with glutathione reductase; oxidized
glutathione is converted to the reduced form in the
presence of glutathione reductase and NADPH, while
NADPH is oxidized to NADP+. The rate of decrease in the
absorbance of NADPH at 340 nm is directly proportional
to GPX activity in a sample. GPX activity was expressed as
nmol/min per ml. The GSH level was measured
spectrophotometrically by a glutathione reductase
recycling method, using a commercial assay kit, according
to the manufacturer’s instructions (Cayman Chemical).
Briefly, the samples were deproteinated by an equal
volume of 10% metaphosphoric acid reagent before
assaying. Into appropriate wells we pipetted 50 µl of
sample or standard, and 150 µl of freshly prepared Assay
Cocktail, according to the manufacturer’s instructions
[MES buffer, cofactor mixture (NADP+ and glucose-6phosphate), enzyme mixture (glutathione reductase and
glucose-6-phosphate dehydrogenase) and 5-5’-dithiobis-
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2-nitrobenzoic acid]. After incubation in the dark on a
shaker, the absorbance in the wells was measured at 405
nm using a plate reader, and the concentrations of
samples were calculated by the end point method. TAC
was measured by a commercially available kit (Cayman
Chemical). The assay method relies on the ability of
antioxidants in the sample to inhibit the oxidation of
®
ABTS (2,2’-Azino-di-[3-ethylbenzthiazoline sulphonate])
®•+
by metmyoglobin. The amount of ABTS®•+
to ABTS
produced can be monitored by reading the absorbance at
750 nm. The capacity of the antioxidants in the sample to
®
prevent ABTS oxidation is compared to that of Trolox
and is quantified as millimolar Trolox equivalents.
All absorbance values were read in an ELISA plate
reader and the concentration of samples were
automatically calculated by software (Power Wave XS;
BIO-TEK Instrument, Inc., KC Junior software). All
samples were run in duplicate, and the 2 measurements
were averaged for statistical analysis.
Data are stated as means ± standard deviation (SD).
When appropriate, differences between group means
were tested by Student’s t-test, chi-square test or MannWhitney U-test (in the data of non-normal distribution).
Correlations between variables were determined by
Spearman’s rank test. All statistical analyses were
performed using SPSS for Windows (version 11.5,
Chicago, IL, USA). A value of P < 0.05 was considered
statistically significant.

Results
There were no significant differences in terms of age
between the control group and stroke patients. The
clinical and laboratory characteristics of the patients and
controls are summarized in Table 1. The mean volume of
3
3
cerebral infarction was 9.5 ± 9.1 cm (range: 1-39 cm ;
3
median: 6.5 cm ).
The antioxidant parameters and MDA results (in
serum and CSF) are presented in Table 2. In the serum
and CSF samples of the stroke patients, GPX activity, GSH
level, and TAC were significantly lower compared to those
in the controls. In the patient group, SOD activity in
serum was lower and SOD activity in CSF was higher
compared to those in the control group. Both serum and
CSF MDA concentrations were significantly higher in the
stroke patients than in the controls.
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Table 1. The characteristics of patients with acute ischemic stroke and control subjects.
Characteristics

Age (years, mean ± SD)

Pa

Controls
(n = 18)

Patients
(n = 32)

55.7 ± 9.3

59.6 ± 10.6

> 0.05

10/8

17/15

> 0.05

Sex (male/female)
Infarct volume, cm3

-

9.5 ± 9.1

-

GCS on admission

-

10.3 ± 2.1

-

Dead

6

-

Vegetative state

4

-

Severely disabled

7

-

Moderately disabled

8

-

Good recovery

7

-

13/19

-

12 (37.5%)

> 0.05

GOS at month

Infarct type
Lacunar / Non-lacunar
Risk factors
Smoking

7 (38.8%)

Alcohol habit

-

-

-

Hypertension

-

18 (56.2%)

-

Diabetes mellitus

-

5 (15.6%)

-

ECG evidence of atrial fibrillation

-

7 (21.9%)

-

a

Calculated using Mann-Whitney U-test or chi-square test as appropriate.
ECG: electrocardiography.

Table 2. Level or activity of some parameters of antioxidants and MDA concentration in serum and CSF in patients with acute ischemic stroke and
controls.
Serum

CSF

Parameters
Controls
(n = 18)

Patients
(n = 32)

P

Controls
(n = 18)

Patients
(n = 32)

SOD (U/ml)

0.221 ± 0.021

0.188 ± 0.031

< 0.001

0.063 ± 0.018

0.078 ± 0.018

< 0.05

GPX (nmol/min per ml)

212.5 ± 39.9

179.9 ± 38.8

< 0.01

36.7 ± 11.2

30.5 ± 12.6

< 0.05

GSH (µmol/l)
TAC (mM Trolox)
MDA (µmol/l)

P

11.8 ± 3.1

9.1 ± 2.0

< 0.005

1.6 ± 1.1

0.8 ± 0.4

< 0.05

0.268 ± 0.043

0.215 ± 0.042

< 0.001

0.081 ± 0.020

0.066 ± 0.016

< 0.05

7.1 ± 2.1

8.6 ± 1.8

< 0.01

4.2 ± 1.6

5.9 ± 2.2

< 0.01

Data are expressed as mean ± SD. CSF: cerebrospinal fluid; SOD: superoxide dismutase; GPX: glutathione peroxidase; GSH: glutathione; TAC: total
antioxidant capacity; MDA: malondialdehyde.

Serum TAC had a nearly significant correlation to CSF
TAC in stroke patients (r = 0.348, P = 0.051) (Figure 1). A
significant negative correlation was observed between TAC
and MDA concentration in CSF samples of the patients (r =
–0.478, P = 0.006) (Figure 2). In patients with ischemic
stroke, CSF MDA level, and CSF antioxidant activity and level
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were not associated with infarction volume. In serum
samples, a significant correlation between infarction volume
and the measured antioxidant parameters was also not
observed. GCS or GOS did not correlate significantly with any
of the measured individual serum and CSF oxidative stress
markers (SOD, GPX, GSH, TAC, and MDA) (data not shown).
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Figure 1. The relationship between CSF TAC and serum TAC in patients
with acute ischemic stroke (r = 0.348, P = 0.051). TAC:
total antioxidant capacity.

Figure 2. The correlation between CSF TAC and CSF MDA levels in
patients with acute ischemic stroke (r = -0.478, P = 0.006).

Discussion

(17,18). Several possible mechanisms involved in the
elevated lipid peroxidation in ischemic stroke have been
proposed. First, cellular membranes in the brain are very
rich in polyunsaturated fatty acids, which are especially
sensitive to free radical attack (19). Second, the brain has
a low content of antioxidant enzymes (i.e. GPX and
catalase), while it contains a significant amount of iron
ions, which stimulate free radical generation (20). In
addition, it has been claimed that lipid peroxidation
products are key mediators of neuronal apoptosis induced
by oxidative stress (21). Alexandrova et al. (22) reported
that the blood concentration of TBA reactive material is
an indicator of the severity of neurological deficit, and is
associated with infarct size and the severity of stroke.
Moreover, Polidori et al. (23) reported a significant
negative correlation between lipid hydroperoxides and
GCS. These reports appear to contradict our results;
however, the absence of a correlation between MDA (TBA
reactive substance) and infarct volume, and GCS or GOS
of the stroke patients in our study may have been due to
different assay methods.

The brain consumes a large quantity of oxygen
because of the high metabolic rate of neurons, making it
particularly susceptible to oxidative stress. Under normal
physiological conditions, there is equilibrium between the
antioxidants and oxidants produced by aerobic cellular
systems. A number of studies documented that ischemic
stroke was associated with increased production of free
radicals in animal and human models (6,13). The direct
measurement of free radicals in biological samples is
difficult because they are extremely reactive and have a
short half-life. Therefore, particularly in human studies,
indirect approaches have been used to demonstrate free
radical production during cerebral ischemia, measuring
the products of free radical reaction with other
molecules, such as lipids, proteins, and DNA, and the level
or activity of antioxidant molecules (14,15).
Lipid peroxidation is a free radical chain reaction,
which arises from the oxidative conversion of
polyunsaturated fatty acids by HO. to lipid peroxides,
which in turn can damage biological membranes (16).
MDA level is widely utilized as a marker of lipid
peroxidation in states of elevated oxidative stress. In the
current study, MDA level in the serum and CSF of the
stroke patient group were higher than those in the
control group, which confirmed previously published data

SOD plays a protective role toward cerebral damage
induced by ischemia (24); however, data associated with
SOD activity after acute ischemic stroke are controversial.
SOD activity in the serum of patients with acute stroke
was reported to be decreased (7) and unchanged (8),,
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while SOD activity after stroke was reported to be
increased in CSF (9), and increased in both CSF and
serum (10). In the present study, we noted reduced
serum SOD activity and increased CSF SOD activity in
stroke patients, which is in accordance with published
data (7,9); however, we did not observe a significant
correlation between infarction volume and CSF SOD
activity. This appeared to contradict the findings reported
by Strand et al. (9). This discrepancy could be explained
by the different SOD isoforms (Cu/Zn-, Mn-, and Fe-SOD)
and differences in the methodology used, as we measured
total SOD (all 3 types of SOD).
GSH is a free radical scavenger and a proton donor for
GPX, which is known to have a neuroprotective role. It is
reported that depletion of total GSH and a decreasing
GSH to GSSG ratio are markers for oxidative stress in an
ischemic brain (5,25). In the present study, the level of
serum and CSF total GSH in acute stroke patients were
significantly lower compared to those in the controls. In
an experimental study, Anderson et al. (26) reported that
intracerebroventricular infusion of glutathione monoethyl
ester reduced infarct volume by more than 60% in a rat
model of stroke. Nevertheless, no correlation between
infarct volume and GSH level in stroke patients was
observed in our study. Weisbrot-Lefkowitz et al. (27)
stated that GPX has protective effects on ischemic brain
injury and reduced GPX activity is associated with an
increased stroke risk. We found a decline in the activity of
serum and CSF GPX in the stroke patients as compared to
the healthy controls; however, our results provide no
information about the association between GPX activity
and GSH level, or the risk of stroke, but these data may
point to an important role for GPX and GSH in acute
stage stroke.
The measurement of TAC has been used to indirectly
assess free-radical activity in biological samples, and may
offer more relevant biological information compared to
that obtained by the measurement of individual
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antioxidant components in plasma and body fluids
(28,29). Nonetheless, experimental and clinical studies of
stroke have focused on individual antioxidant molecules
rather than overall antioxidant defense, and to the best of
our knowledge there is no information in the literature on
the simultaneous evaluation of TAC in serum and CSF in
acute ischemic stroke. In this study we found that TAC
was reduced in stroke patients compared to controls,
which indicates that the observed decrease in TAC was
partly due to the decreased activity or level of SOD, GPX,
and GSH, and the accumulation of lipid peroxidation
products in serum and CSF. Gariballa et al. (1) reported
that TAC was reduced in the serum of patients 48-72 h
following stroke onset compared to controls, which is in
accordance with our results. Leinonen et al. (6) examined
total peroxyl radical-trapping potential in the plasma and
CSF of patients with acute ischemic stroke by a
chemiluminescence-enhanced method. Their data showed
an association between plasma total antioxidant activity
and the volume of ischemic cerebral infarction.
Nevertheless, in this study we did not find any correlation
between infarction volume with serum or CSF TAC in
stroke patients.
In summary, once generated, free radicals can react
with all cellular macromolecules, including proteins, and
protein oxidation, particularly of enzymes, can lead to
impairment of their function (30). In the present study,
the decreased activity or level of antioxidant molecules
measured could have resulted from increased free radical
generation, which may confirm the presence of oxidative
stress in acute ischemic stroke. Despite the data in the
scientific literature, we did not find any significant
correlation between infarct volume, GCS or GOS, and the
measured individual serum and CSF oxidative stress
markers. Therefore, SOD and GPX activity, and TAC,
GSH, and MDA levels in serum and CSF in patients with
acute ischemic stroke may not always be an indicator of
the severity of neurological defect.
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